Explore more Johnson & Johnson sites:
Share
Back to top
Global Public Health
Our Commitment to Global Health Equity
s the world’s largest healthcare company, we are driven to foster better health for more people in more places around the world.
While the world has made significant progress in providing improved healthcare, major gaps remain. Exascerbated by the COVID-19 pandemic, bolder, smarter approaches are needed to overcome the drastic inequity in access to care—now more than ever.
Through a dedicated global public health (GPH) organization that combines world-class research and development, global strategy and external affairs capabilities, and local implementation and impact teams, we put the world’s most underserved at the heart of everything we do—measuring our success in lives improved.
As a team of innovators, we are committed to pioneering and sustainably delivering meaningful and transformational products in areas where we believe we can make a profound difference: from expanding access to care in HIV, Tuberculosis and global mental health to addressing & preventing future pandemics. Working with global and local partners, we ensure the critical solutions necessary are within reach of those who need them to save lives, cure patients and prevent disease.
Upholding the rich heritage of Johnson & Johnson, we are taking on the toughest challenges, and, ultimately, we will do our part to close the gap of inequity and pave the way to a healthier future where all people and communities can thrive.
How We Deliver Equitable Access to Care
Develop Holistic and Impactful Solutions to Ensure Our Transformational Innovations Are Available, Affordable and Accessible
Enable, Advance and Unlock Breakthrough Science for Global Health Challenges
Focus, Convene and Advocate to Move the World’s Health Forward, Faster
Our commitment to advancing global health equity is a core priority embedded in our environmental, social and governance (ESG) strategy to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere.
Where We Focus
Featured Efforts That Advance Equitable Access to Care
-
The Access to Medicine Index, a ranking of pharmaceutical companies' work to distribute medications to low- and middle-income countries, just named Johnson & Johnson #3 on its biennial list, underscoring the company's deep history of ensuring people in underserved communities receive the treatments they need.
-
InnovationHow are drones being used to transform HIV care for one Ugandan district? From Kalangala, Devex takes a look.
Leader Perspectives on Equitable Access
The Global Public Health organization works in collaboration to drive transformational impact from the lab bench to the last mile of health, discovering, developing and delivering innovation that can tackle entrenched and emerging challenges alike and empower more people to live healthier lives.
Johnson & Johnson has a long history of developing innovative medicines and technologies, and we continue to strengthen our R&D pipeline to turn science into solutions for the world’s most vulnerable communities.
Johnson & Johnson's Global Public Health unit is a model in the industry on access planning and results for several therapeutic areas, and it's constantly challenging itself to do more.
Social Media Updates
-
Congrats to #JNJ @anil_koul1 for being featured in @BiovoiceNews list of top bioscience innovators in India for his work to #EndTB! Dr. Koul has played a key role in discovering and developing an innovative multidrug-resistant TB treatment. Read more: https://t.co/4trqOKb2Qd https://t.co/4uIB6KZIBr
-
10 years ago, our first-of-its-kind multidrug-resistant #TB treatment was approved. Since then, we’ve worked to transform the TB care landscape through powerful partnerships, delivering 600K courses of medicine and working to increase access. Learn more ⬇️ https://t.co/vETX8zyTHa
-
RT @GlobalFund: Today is #WorldTBDay. We must make the fight to #EndTB equitable, rights-based, & people-centered. Together, we must acce…
News & Press Releases
-
InnovationJuly 26, 2021
